Your browser doesn't support javascript.
loading
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
McMichael, Elizabeth L; Benner, Brooke; Atwal, Lakhvir S; Courtney, Nicholas B; Mo, Xiaokui; Davis, Melanie E; Campbell, Amanda R; Duggan, Megan C; Williams, Kallan; Martin, Kyle; Levine, Kala; Olaverria Salavaggione, Gonzalo N; Noel, Tiffany; Ganju, Akaansha; Uppati, Sarvani; Paul, Bonnie; Olencki, Thomas; Teknos, Theodoros N; Savvides, Panos; Tridandapani, Susheela; Byrd, John C; Caligiuri, Michael A; Liu, Stephen V; Carson, William E.
Afiliação
  • McMichael EL; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Benner B; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Atwal LS; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Courtney NB; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Mo X; Center for Biostatistics, The Ohio State University, Columbus, Ohio.
  • Davis ME; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Campbell AR; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Duggan MC; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Williams K; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Martin K; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Levine K; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Olaverria Salavaggione GN; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Noel T; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Ganju A; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Uppati S; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Paul B; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Olencki T; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
  • Teknos TN; Department of Otolaryngology, The Ohio State University, Columbus, Ohio.
  • Savvides P; Department of Medicine, Division of Hematology/Oncology, The Ohio State University, Columbus, Ohio.
  • Tridandapani S; Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
  • Byrd JC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, Ohio.
  • Caligiuri MA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, Ohio.
  • Liu SV; Department of Medicine, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, D.C.
  • Carson WE; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio. william.carson@osumc.edu.
Clin Cancer Res ; 25(16): 4955-4965, 2019 08 15.
Article em En | MEDLINE | ID: mdl-31142501
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Escamosas de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Escamosas de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article